Website
VCID: 112466
Profile
Funding
Funding rounds
(1 Jul 2009)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Biogen Idec Inc | United States | ||
|
CMEA Capital | United States | ||
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Abingworth Bioventures V LP | Venture capital fund | United Kingdom | Initial investment. Round participant. |
|
Novartis Services Inc | United States | Initial investment. Round participant. | |
|
US Venture Partners. | Silicon Valley venture capital firm. | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Abingworth Bioventures V LP Venture capital fund |
+44 (20) 7534-1500 |
N/A |
|
|
Biogen Idec Inc |
Series B | |
|
|
CMEA Capital |
+1 (415) 352-1520 |
Series B |
|
|
Novartis Services Inc |
+1 (617) 871-3536 |
N/A |
|
|
Novartis Venture Funds The corporate venturing arm of Novartis. |
+41 (61) 324-6210 |
Series B |
|
Sofinnova Ventures Inc |
+1 (415) 228-3380 |
Series B |
|
|
US Venture Partners. Silicon Valley venture capital firm. |
+1 (650) 854-9080 |
N/A |